Nephros (NEPH) Net Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Nephros (NEPH) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -562.77% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | -9.88% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 83.30% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 2,827.78% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -395.56% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 168.38% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -593.75% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | -103.49% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | -54.17% |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | -31.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.62% |
| Mar 31, 2026 | -530.53% |
| Dec 31, 2025 | -85.88% |
| Sep 30, 2025 | 115.57% |
| Jun 30, 2025 | 297.42% |
| Mar 31, 2025 | 147.63% |
| Dec 31, 2024 | 572.10% |
| Sep 30, 2024 | -204.18% |
| Jun 30, 2024 | -324.55% |
| Mar 31, 2024 | -433.66% |
| Dec 31, 2023 | 9.80% |
| Sep 30, 2023 | 350.21% |
| Jun 30, 2023 | 118.04% |
| Mar 31, 2023 | 113.03% |
| Dec 31, 2022 | 17.74% |
| Sep 30, 2022 | 74.19% |
| Jun 30, 2022 | -1,189.47% |
| Mar 31, 2022 | -1,813.58% |
| Dec 31, 2021 | -112.04% |
| Sep 30, 2021 | 51.13% |